ASP9521

ASP9521 · Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP9521, covering 2014-03-24 to 2014-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients [Phase 1, Phase 2]